Miguel Alcoceba

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

Ferran Nadeu, Julio Delgado, Cristina Royo et al. · Blood · 2016 · 327 citations · Full text

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia

Cristina Jiménez, Elena Sebastián, Carmen Chillón et al. · Leukemia · 2013 · 264 citations

Myd88 L265p, Disease Mechanism, Genetic Disorder +6

Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis

María Eugenia Sarasquete, Ramón García‐Sánz, Miguel Alcoceba et al. · Blood · 2008 · 235 citations · Full text

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

Kennosuke Karube, Anna Enjuanes, Iván Dlouhy et al. · Leukemia · 2017 · 178 citations · Full text

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry

Noemí Puig, María Eugenia Sarasquete, Ana Balanzategui et al. · Leukemia · 2013 · 168 citations

Hematological Malignancy, Oncology, Medicine +11